Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold, Silver & Bullion  :  Gems and jewellery exports dip by 8.67% to Rs 2,64,130.64 crore in FY18

27-Apr2018

Gems and jewellery exports dip by 8.67% to Rs 2,64,130.64 crore in FY18

The gems and jewellery exports have declined by 8.67% to Rs 2,64,130.64 crore in financial year 2017-18. As per data compiled by the industry body the Gem and Jewellery Export Promotion Council (GJEPC), this decline is mainly due to drop in demand from the UAE. The exports stood at Rs 2,89,207.47 crore in 2016-17.

The demand from the UAE declined by 27% to Rs 66,862.98 crore during FY18, compared with Rs 91,458.57 crore in the previous year, on a 5% value added tax (VAT) imposed in the UAE in January. Major export destinations for the gems and jewellery sector in 2017-18 were Hong Kong with 33%, followed by the UAE with 25% and the US at 23%.

The exports in the sector was primarily driven by the cut and polished diamonds (CPD) segment, which witnessed an increase of 0.18% to Rs 1,52,961.38 crore in FY18, compared with Rs 1,52,682.59 crore in FY17.


Related News

View all news

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures decline on firming dollar

Gold futures declined on MCX as traders await the minutes from the US Federal Reserve's latest policy meeting for fresh clues on the pace of interest rate hikes. Besides, a firming dollar against some......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......